Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, cancer, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm	Recruiting	Not stated	2026-09-14		NCT02869802

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
American Society of Clinical Oncology	17
BC Cancer Foundation	9
British Columbia Cancer Agency	58
Pancreas Centre BC	1
Terry Fox Research Institute	8

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
BC Cancer - Vancouver	Vancouver	Canada	15
Cross Cancer Institute	Edmonton	Canada	146
The Ottawa Hospital	Ottawa	Canada	47
Tom Baker Cancer Centre	Calgary	Canada	29